CBR Genomics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

CBR Genomics General Information

Description

Developer of a digital health platform intended to simplify and modernize how genetics tests are accessed, purchased, and managed. The company's platform facilitates an easy-to-use digital tool that bridges genomic knowledge and medical practice, enabling physicians to generate personalized diagnosis and prognosis reports in a safe, secure, and efficient way, adapting the treatment plan and prescriptions taking into account the patient's genomic information.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Biocant, Parque Tecnológico de Cantanhede
  • Núcleo 04, Lote 3
  • Cantanhede, 3060-197
  • Portugal
+351 304
Primary Industry
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Biocant, Parque Tecnológico de Cantanhede
  • Núcleo 04, Lote 3
  • Cantanhede, 3060-197
  • Portugal
+351 304

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CBR Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 22-Aug-2023 Completed Out of Business
4. Later Stage VC 01-Jan-2021 Completed Generating Revenue
3. Merger/Acquisition 01-Jan-2020 Completed Generating Revenue
2. Early Stage VC 13-Dec-2017 $2.84M $5.87M Completed Product Development
1. Seed Round 01-Jul-2013 $3.03M $3.03M Completed Startup
To view CBR Genomics’s complete valuation and funding history, request access »

CBR Genomics Patents

CBR Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3380982-A1 Genome query handling Active 16-Dec-2015
EP-3380982-B1 Genome query handling Active 16-Dec-2015
US-10726155-B2 Genome query handling Inactive 16-Dec-2015
US-20180365446-A1 Genome query handling Active 16-Dec-2015
WO-2017102390-A1 Genome query handling Inactive 16-Dec-2015 G06F21/6254
To view CBR Genomics’s complete patent history, request access »

CBR Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CBR Genomics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Universidade de Coimbra University
To view CBR Genomics’s complete investors history, request access »

CBR Genomics FAQs

  • When was CBR Genomics founded?

    CBR Genomics was founded in 2013.

  • Where is CBR Genomics headquartered?

    CBR Genomics is headquartered in Cantanhede, Portugal.

  • What is the size of CBR Genomics?

    CBR Genomics has 14 total employees.

  • What industry is CBR Genomics in?

    CBR Genomics’s primary industry is Other Healthcare Technology Systems.

  • Is CBR Genomics a private or public company?

    CBR Genomics is a Private company.

  • What is CBR Genomics’s current revenue?

    The current revenue for CBR Genomics is .

  • How much funding has CBR Genomics raised over time?

    CBR Genomics has raised $5.87M.

  • Who are CBR Genomics’s investors?

    Universidade de Coimbra has invested in CBR Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process